At this year's Classical Hematology Conference we will be joined by Hematology experts, Adam Cuker, M.D. and Stephan Moll, M.D. Reserve your spot today.

William Morice II, M.D., Ph.D., highlights data-driven reasons health systems benefit from the lab service line and strategies to bolster performance.

Review the art of delivering clear, constructive feedback; tips for navigating potentially challenging conversations with respect; highlighting the importance of positive feedback.

This week's research roundup features: Identification of caveolae-associated protein 4 autoantibodies as a biomarker of immune-mediated rippling muscle disease in adults.

Darci Block, Ph.D., of the Department of Laboratory Medicine and Pathology at Mayo Clinic, authored an article in the American Association for Clinical Chemistry’s (AACC) Clinical Laboratory News highlighting hurdles in body fluid testing.

Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology in the Department of Laboratory Medicine and Pathology at Mayo Clinic and director of the Clinical Parasitology Laboratory, provides her perspective on parasites in the latest edition of National Geographic magazine.

Topic highlights include: Mayo Clinic doctors weigh in on all things back-to-school, Trial seeks to develop first Lyme disease vaccine in 2 decades, New York health department says hundreds of people may be infected with polio virus.

In this episode, Dr. Pritt and Dr. Morice discuss new developments in monkeypox testing, updates on the federal response, and lessons learned from managing other viruses.

In a recent study, Mayo Clinic researchers developed the first cellular DNA barcoding with a machine-learning approach to reveal previously unknown metastatic behavior of tumor cells. Researchers barcoded the DNA of millions of human ovarian cancer cells and transplanted them in mice, where rare tumor initiating cells and their progenies could be tracked within the primary tumor as well as in every other organ they were spreading into. The entire community of cells generated by a single barcoded cell had identical barcodes. This enabled the tracking of a large number of benign and metastatic clones by sequencing DNA barcodes in tumors and various organs, including blood and ascites. Using the cellular DNA barcoding approach and a newly developed data analysis system, researchers could track clonal growth dynamics in various metastatic sites and trace it back to its ancestral tumor-initiating cell. They used artificial intelligence to tackle the complex data to identify if the clonal metastatic spread is happening peritoneally or through blood routes.

Rong He, M.D., describes how Mayo Clinic Laboratories’ NPM1Q assay detects all known forms of a genetic mutation found in about 30% of people with acute myeloid leukemia, or AML. Identifying the NPM1 mutation is critical for clinical decision-making.

This week's research roundup features: Type 1, type 2 myocardial infarction and non-ischemic myocardial injury-opinion from the front lines

At just 24-years-old Anya Magnuson has survived not just one but two close encounters with death. Focused, determined, and intent on experiencing life to its fullest, Anya never gave up. Nor did the multidisciplinary Mayo Clinic care team who worked tirelessly to heal her.

Topic highlights include: Mayo: urgent need for O- blood types, Optum, Sanofi team to make low-cost insulin available to uninsured, How the COVID-19 pandemic changed Americans’ health for the worse.

In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., sits down with Bobbi Pritt, M.D., professor of Laboratory Medicine and Pathology and division chair for the Department of Clinical Microbiology at Mayo Clinic, to discuss why this year’s tick season is more severe than others.

In July 2022, Mayo Clinic Laboratories announced fifteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.